Clinical Trial Update: Kerlix for Pregnant Women With Elevated BMI to Prevent Wound Infection by 6 Weeks Post Partum [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining whether Kerlix wound dressings can reduce postpartum wound infections in pregnant women with elevated BMI within 6 weeks…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Pregnancy
• Wound Infection

Drugs mentioned

• Kerlix

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Obesity, Wound Infection | Phase 4 | Status: UNKNOWN